Get help now — free helplines

You can call any of these for free. You do not need a diagnosis, an appointment, or a crisis to call — questions and plain exhaustion are reasons enough.

  • Alzheimer's Association 24/7 Helpline 800-272-3900 24 hours a day, 365 days a year Free, confidential support and information for people with dementia, caregivers, families and the public. Master's-level clinicians. Also Spanish.
  • 988 Suicide & Crisis Lifeline 988 24/7 Call or text 988, or chat at 988lifeline.org. For anyone in emotional distress or a mental-health crisis, including caregivers.
  • Alzheimer's Foundation of America (AFA) Helpline 866-232-8484 9:00 am - 9:00 pm ET, seven days a week Licensed social workers providing support, info and referrals. Also text message and web chat. Text: 646-586-5283

In a medical emergency, call 911. More numbers, and what each line does, on the help page.

What "newest" means here

The most recent study in this library is dated 2026-11-01 (Paths of Aging Minds: Health Journeys of Older Adults with Mild Cognitive Impairment). This is our summary library, not a news wire — it is added to in batches, so the newest entry may not be the newest paper published anywhere.

Entries are sorted strictly by publication date, newest first. 26489 of the 27380 entries carry a full day-level date. 65 have no date recorded at all and are placed by publication year, at the start of that year; those are marked "no date recorded" below so you can see where the ordering is a best effort rather than a fact.

Prefer a reader? Subscribe to the Atom feed. Want them sorted by subject or by score instead? Browse the research library.

Showing 7,526–7,550 of 27,380 studies, newest first · page 302 of 1096.

July 2023 25

  1. 2023-07-07

    The gut-brain vascular axis in neuroinflammation

    ✓ Peer-reviewed Disease mechanisms Seminars in immunology

    Key finding: Microbial dysbiosis is reported in several inflammatory intestinal diseases characterized by the impairment of the gut epithelial and vascular barriers, defined as leaky gut, and it is reported as a potential danger condition associated with the development of metabolic, inflammatory and neurodegenerative diseases.

  2. 2023-07-07

    A History of Repeated Alcohol Intoxication Promotes Cognitive Impairment and Gene Expression Signatures of Disease Progression in the 3xTg Mouse Model of Alzheimer's Disease

    ✓ Peer-reviewed Genetics eNeuro

    Key finding: We observed a broad dysregulation of gene expression that involves neuronal excitability, neurodegeneration, and inflammation, including interferon genes. +2 more findings

  3. 2023-07-07

    Efficacy and safety of anti-amyloid-β monoclonal antibodies in current Alzheimer's disease phase III clinical trials: A systematic review and interactive web app-based meta-analysis

    ✓ Peer-reviewed Treatments Ageing research reviews

    Key finding: The risk-benefit profile of anti-Aβ monoclonal antibodies (mAbs) in Alzheimer's disease (AD) remains unclear, especially concerning their safety and overall effects on AD progression and cognitive function. +3 more findings

  4. 2023-07-07

    Developing a machine learning model for detecting depression, anxiety, and apathy in older adults with mild cognitive impairment using speech and facial expressions: A cross-sectional observational study

    ✓ Peer-reviewed Digital health tools International journal of nursing studies

    Key finding: The machine learning model developed in this study demonstrated strong classification performance in detecting and differentiating depression, anxiety, and apathy. +2 more findings

  5. 2023-07-06

    APOE genotypes modify the obesity paradox in dementia

    ✓ Peer-reviewed Genetics Journal of neurology, neurosurgery, and psychiatry

    Key finding: Obesity was associated with cognitive decline in early elderly cognitively normal individuals without APOE4, especially those with APOE2. +4 more findings

  6. 2023-07-06

    FDA Converts Novel Alzheimer's Disease Treatment to Traditional Approval

    ⚠ Regulatory decision — not a study Treatments U.S. Food and Drug Administration

    Key finding: Based on the Clarity AD Phase 3 trial (n=1,795) showing statistically significant slowing of cognitive/functional decline over 18 months vs placebo +2 more findings

  7. 2023-07-05

    Passive Alzheimer's immunotherapy: A promising or uncertain option?

    ✓ Peer-reviewed Treatments Ageing research reviews

    Key finding: Two antibodies, donanemab and lecanemab, have demonstrated clinical efficacy, but these results remain uncertain. +1 more finding

  8. 2023-07-05

    Proteomics of brain, CSF, and plasma identifies molecular signatures for distinguishing sporadic and genetic Alzheimer's disease

    ✓ Peer-reviewed TREM2 and immune genetics Science translational medicine

    Key finding: Here, we present a proteomic study analyzing 1305 proteins in brain tissue, cerebrospinal fluid (CSF), and plasma from patients with sporadic AD, TREM2 risk variant carriers, patients with autosomal dominant AD (ADAD), and healthy individuals. +3 more findings

  9. 2023-07-03

    Riding the merry-go-round of racial disparities in ADRD research

    ✓ Peer-reviewed Disparities Alzheimer's & dementia : the journal of the Alzheimer's Association

    Key finding: With the rapid expansion of the aging population, the burden of Alzheimer's disease related dementias (ADRD) is anticipated to increase in racialized and minoritized groups who are at disproportionately higher risk. +1 more finding

  10. 2023-07-03

    Data-driven neuropathological staging and subtyping of TDP-43 proteinopathies

    ✓ Peer-reviewed Brain tissue and pathology Brain : a journal of neurology

    Key finding: In LATE-NC individuals, progression along data-driven stages was positively associated with age, but negatively associated with age in individuals with FTLD-TDP. +2 more findings

  11. 2023-07-03

    Effects of Exercise Alone or Combined With Cognitive Training and Vitamin D Supplementation to Improve Cognition in Adults With Mild Cognitive Impairment: A Randomized Clinical Trial

    ✓ Peer-reviewed Prevention trials JAMA network open

    Key finding: In this clinical trial, older adults with MCI receiving aerobic-resistance exercises with sequential computerized cognitive training significantly improved cognition, although some results were inconsistent. +4 more findings

  12. 2023-07-03

    Sleep Architecture, Obstructive Sleep Apnea, and Cognitive Function in Adults

    ✓ Peer-reviewed Long-term cohort studies JAMA network open

    Key finding: Good sleep is essential for health, yet associations between sleep and dementia risk remain incompletely understood. +3 more findings

  13. 2023-07-03

    Effects of Meditation Training and Non-Native Language Training on Cognition in Older Adults: A Secondary Analysis of a Randomized Clinical Trial

    ✓ Peer-reviewed Treatments JAMA network open

    Key finding: Among 137 randomized participants, 2 were excluded for not meeting eligibility criteria, leaving 135 (mean [SD] age, 69.3 [3.8] years; 83 female [61%]) eligible for analysis. +2 more findings

  14. 2023-07-01
  15. 2023-07-01

    Economic burden of comorbid insomnia in 5 common medical disease subgroups

    ✓ Peer-reviewed Costs and economics Journal of clinical sleep medicine : JCSM : official publication of the American Academy of Sleep Medicine

    Key finding: Sample sizes for individuals with comorbid insomnia ranged from 23,168 (T2DM) to 3,015 (ADRDs). +4 more findings

  16. 2023-07 month only

    Associations between air pollution and mental health service use in dementia: a retrospective cohort study

    ✓ Peer-reviewed Risk factors BMJ mental health

    Key finding: In the first year of follow-up, increased exposure to all air pollutants was associated with an increase in the use of CMHTs in a dose-response manner. +4 more findings

  17. 2023-07-01

    A Novel Formulation: Donepezil Patch

    ✓ Peer-reviewed Treatments The Senior care pharmacist

    Key finding: Prevalence of dementia continues to increase with limited pharmacotherapy options available. +4 more findings

  18. 2023-07-01

    Human brain single nucleus cell type enrichments in neurodegenerative diseases

    ⚠ Preprint — not yet peer-reviewed Genetics medRxiv : the preprint server for health sciences

    Key finding: We were able to identify significant immune-related cell types in the brain across three major neurodegenerative diseases: Alzheimer's Disease, Amyotrophic Lateral Sclerosis, and Parkinson's Diseases.

    Scored 20 on our rubric, shown as 16: non-peer-reviewed sources are capped at 16. See the breakdown.

  19. 2023-07-01

    Advances in amyloid-targeting monoclonal antibodies for Alzheimer's disease: clinical and public health issues

    ✓ Peer-reviewed Treatments Expert review of neurotherapeutics

    Key finding: Alzheimer's disease (AD) is a major global public health challenge. +4 more findings

  20. 2023-07-01

    Palliative care to support the needs of adults with neurological disease

    ✓ Peer-reviewed End-of-life care The Lancet. Neurology

    Key finding: Palliative care focuses on improving quality of life for people with serious illness and their families by addressing this multidimensional suffering. +4 more findings

  21. 2023-07-01

    Estimates of diagnosed dementia prevalence and incidence among diverse beneficiaries in traditional Medicare and Medicare Advantage

    ✓ Peer-reviewed Health systems and care delivery Alzheimer s & Dementia Diagnosis Assessment & Disease Monitoring

    Key finding: The diagnosed dementia incidence rate was also lower in MA (2.50%; 95% CI: 2.50 to 2.50) compared to TM (2.99%; 95% CI: 2.99 to 2.99). +2 more findings

  22. 2023-07-01

    Development and validation of a dementia risk score in the UK Biobank and Whitehall II cohorts

    ✓ Peer-reviewed Long-term cohort studies BMJ mental health

    Key finding: Current dementia risk scores have had limited success in consistently identifying at-risk individuals across different ages and geographical locations. +3 more findings

  23. 2023-07-01

    Correlation between insulin-degrading enzyme versus total tau and selected cytokines in patients with Alzheimer´s disease compared to non-demented controls

    ✓ Peer-reviewed Tau biomarkers Neuro endocrinology letters

    Key finding: It has been increasingly recognized that the pathological progress of Alzheimer´s disease (AD) is connected to metabolic function and inflammation. +3 more findings

  24. 2023-07-01

    Integrated single-cell analysis-based classification of vascular mononuclear phagocytes in mouse and human atherosclerosis

    ✓ Peer-reviewed TREM2 and immune genetics Cardiovascular research

    Key finding: Accumulation of mononuclear phagocytes [monocytes, macrophages, and dendritic cells (DCs)] in the vessel wall is a hallmark of atherosclerosis. +3 more findings

  25. 2023-07-01

    Association Between Acute Myocardial Infarction and Cognition

    ✓ Peer-reviewed Disparities JAMA neurology

    Key finding: This cohort study using pooled data from 6 cohort studies found that incident MI was not associated with a decrease in global cognition, memory, or executive function at the time of the event compared with no MI but was associated with faster declines in global cognition, memory, and executive function over time. +4 more findings

Browse the library by subject, with the full score breakdown →